These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 18226001

  • 21. Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.
    Todd DJ, Kagan A, Chibnik LB, Kay J.
    Arthritis Rheum; 2007 Oct; 56(10):3433-41. PubMed ID: 17907148
    [Abstract] [Full Text] [Related]

  • 22. Nephrogenic systemic fibrosis--implications for nephrologists.
    Saab G, Abu-Alfa A.
    Eur J Radiol; 2008 May; 66(2):208-12. PubMed ID: 18342470
    [Abstract] [Full Text] [Related]

  • 23. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
    Kay J.
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
    [Abstract] [Full Text] [Related]

  • 24. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 25. The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report.
    Wiedemeyer K, Kutzner H, Abraham JL, Thakral C, Carlson JA, Tran TA, Hausser I, Hartschuh W.
    Am J Dermatopathol; 2009 Oct 01; 31(7):674-81. PubMed ID: 19633532
    [Abstract] [Full Text] [Related]

  • 26. Nephrogenic systemic fibrosis: a nephrologist's perspective.
    Saab G, Cheng S.
    Hemodial Int; 2007 Oct 01; 11 Suppl 3():S2-6. PubMed ID: 17897106
    [Abstract] [Full Text] [Related]

  • 27. Gadolinium and nephrogenic systemic fibrosis: association or causation.
    Kurtkoti J, Snow T, Hiremagalur B.
    Nephrology (Carlton); 2008 Jun 01; 13(3):235-41. PubMed ID: 18221255
    [Abstract] [Full Text] [Related]

  • 28. Nephrogenic systemic fibrosis and gadolinium-based contrast: medico-legal implications.
    Houck CM, Pristave RJ, Kannensohn KJ.
    Semin Dial; 2008 Jun 01; 21(2):166-70. PubMed ID: 18226003
    [Abstract] [Full Text] [Related]

  • 29. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
    Broome DR.
    Eur J Radiol; 2008 May 01; 66(2):230-4. PubMed ID: 18372138
    [Abstract] [Full Text] [Related]

  • 30. The impact of NSF on the care of patients with kidney disease.
    Abu-Alfa A.
    J Am Coll Radiol; 2008 Jan 01; 5(1):45-52. PubMed ID: 18180009
    [Abstract] [Full Text] [Related]

  • 31. Can the risk of gadolinium be extrapolated to lanthanum?
    De Broe ME.
    Semin Dial; 2008 Jan 01; 21(2):142-4. PubMed ID: 18248522
    [Abstract] [Full Text] [Related]

  • 32. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
    Wiginton CD, Kelly B, Oto A, Jesse M, Aristimuno P, Ernst R, Chaljub G.
    AJR Am J Roentgenol; 2008 Apr 01; 190(4):1060-8. PubMed ID: 18356456
    [Abstract] [Full Text] [Related]

  • 33. Nephrogenic systemic fibrosis: recommendations for gadolinium-based contrast use in patients with kidney disease.
    Perazella MA, Reilly RF.
    Semin Dial; 2008 Apr 01; 21(2):171-3. PubMed ID: 18226005
    [Abstract] [Full Text] [Related]

  • 34. Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis.
    Richmond H, Zwerner J, Kim Y, Fiorentino D.
    Arch Dermatol; 2007 Aug 01; 143(8):1025-30. PubMed ID: 17709661
    [Abstract] [Full Text] [Related]

  • 35. Nephrogenic systemic fibrosis and management of high-risk patients.
    Altun E, Semelka RC, Cakit C.
    Acad Radiol; 2009 Jul 01; 16(7):897-905. PubMed ID: 19375360
    [Abstract] [Full Text] [Related]

  • 36. Nephrogenic systemic fibrosis with a spectrum of clinical and histopathological presentation: a disorder of aberrant dermal remodeling.
    Deng A, Martin DB, Spillane A, Chwalek J, St Surin-Lord S, Brooks S, Petrali J, Sina B, Gaspari A, Kao G.
    J Cutan Pathol; 2010 Feb 01; 37(2):204-10. PubMed ID: 19341434
    [Abstract] [Full Text] [Related]

  • 37. Nephrogenic systemic fibrosis: clinical spectrum of disease.
    Mayr M, Burkhalter F, Bongartz G.
    J Magn Reson Imaging; 2009 Dec 01; 30(6):1289-97. PubMed ID: 19937929
    [Abstract] [Full Text] [Related]

  • 38. [Nephrogenic systemic fibrosis].
    Cavallini L, Abaterusso C, Bedogna V, Pertica N, Loschiavo C, Lupo A.
    G Ital Nefrol; 2008 Dec 01; 25(1):14-20. PubMed ID: 18264914
    [Abstract] [Full Text] [Related]

  • 39. Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review.
    Sanyal S, Marckmann P, Scherer S, Abraham JL.
    Nephrol Dial Transplant; 2011 Nov 01; 26(11):3616-26. PubMed ID: 21441397
    [Abstract] [Full Text] [Related]

  • 40. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis in 2 patients with end-stage renal disease on hemodialysis.
    Kim RH, Ma L, Hayat SQ, Ahmed MM.
    J Clin Rheumatol; 2006 Jun 01; 12(3):134-6. PubMed ID: 16755242
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.